Literature DB >> 7697923

Differing antibody IgG isotypes in the polar forms of leprosy and cutaneous leishmaniasis characterized by antigen-specific T cell anergy.

M Ulrich1, V Rodriguez, M Centeno, J Convit.   

Abstract

Leprosy and American cutaneous leishmaniasis are tropical diseases which present a spectrum of clinical and immunological manifestations. Lepromatous leprosy and diffuse cutaneous leishmaniasis are the severe, progressive polar forms of disease characterized by persistent T cell anergy. Relative concentrations of antibodies belonging to the four IgG isotypes have been determined in these forms of disease as well as active visceral leishmaniasis, which presents transitory T cell anergy. Leishmania-specific IgG4 antibodies predominated in 19/20 sera from patients with diffuse cutaneous leishmaniasis, and IgG1 antibodies predominated in 9/10 cases of untreated visceral leishmaniasis. The predominant IgG isotype of Mycobacterium leprae-specific antibodies in untreated lepromatous leprosy was remarkably variable (IgG1, IgG2, IgG3 and IgG4 in 8, 6, 2 and 1 sera, respectively). Differing IgG antibody isotypes have been associated with distinct CD4+ T cell helper subpopulations and their characteristic lymphokine profiles in several pathologies. These results suggest that T cell anergy in chronic intracellular infections may be associated with as yet undefined mechanisms which modulate reported T helper cell-lymphokine isotype relationships.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7697923      PMCID: PMC1534253          DOI: 10.1111/j.1365-2249.1995.tb03603.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Histologic responses in sixty multibacillary leprosy patients inoculated with autoclaved Mycobacterium leprae and live BCG.

Authors:  W M Meyers; A C McDougall; R N Fleury; R Neves; O Reyes; C H Binford
Journal:  Int J Lepr Other Mycobact Dis       Date:  1988-06

2.  The Kellersberger Memorial Lecture: leprosy and leishmaniasis similar clinical-immunological-pathological models.

Authors:  J Convit
Journal:  Ethiop Med J       Date:  1974-10

3.  Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study.

Authors:  R Jefferis; C B Reimer; F Skvaril; G de Lange; N R Ling; J Lowe; M R Walker; D J Phillips; C H Aloisio; T W Wells
Journal:  Immunol Lett       Date:  1985       Impact factor: 3.685

4.  An analysis of T cell responsiveness in Indian kala-azar.

Authors:  D L Sacks; S L Lal; S N Shrivastava; J Blackwell; F A Neva
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

5.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

Authors:  T R Mosmann; H Cherwinski; M W Bond; M A Giedlin; R L Coffman
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

6.  Immunotherapy with a mixture of Mycobacterium leprae and BCG in different forms of leprosy and in Mitsuda-negative contacts.

Authors:  J Convit; N Aranzazu; M Ulrich; M E Pinardi; O Reyes; J Alvarado
Journal:  Int J Lepr Other Mycobact Dis       Date:  1982-12

Review 7.  The American leishmaniases: some observations on their ecology and epidemiology.

Authors:  R Lainson
Journal:  Trans R Soc Trop Med Hyg       Date:  1983       Impact factor: 2.184

8.  The clinical and immunological spectrum of American cutaneous leishmaniasis.

Authors:  J Convit; M Ulrich; C T Fernández; F J Tapia; G Cáceres-Dittmar; M Castés; A J Rondón
Journal:  Trans R Soc Trop Med Hyg       Date:  1993 Jul-Aug       Impact factor: 2.184

9.  Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.

Authors:  E M Carvalho; R Badaró; S G Reed; T C Jones; W D Johnson
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

10.  Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.

Authors:  F P Heinzel; M D Sadick; B J Holaday; R L Coffman; R M Locksley
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

View more
  9 in total

1.  Antigen-specific B-cell unresponsiveness induced by chronic Mycobacterium avium subsp. paratuberculosis infection of cattle.

Authors:  W R Waters; J R Stabel; R E Sacco; J A Harp; B A Pesch; M J Wannemuehler
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

2.  Detection of specific antibody isotypes and subtypes before and after treatment of American visceral leishmaniasis.

Authors:  V L da Matta; S Hoshino-Shimizu; R Dietze; C E Corbett
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

3.  Differential decline in Leishmania membrane antigen-specific immunoglobulin G (IgG), IgM, IgE, and IgG subclass antibodies in Indian kala-azar patients after chemotherapy.

Authors:  K Anam; F Afrin; D Banerjee; N Pramanik; S K Guha; R P Goswami; S K Saha; N Ali
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

4.  Immunoglobulin subclass distribution and diagnostic value of Leishmania donovani antigen-specific immunoglobulin G3 in Indian kala-azar patients.

Authors:  K Anam; F Afrin; D Banerjee; N Pramanik; S K Guha; R P Goswami; P N Gupta; S K Saha; N Ali
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

5.  Sin nombre virus (SNV) Ig isotype antibody response during acute and convalescent phases of hantavirus pulmonary syndrome.

Authors:  P Bostik; J Winter; T G Ksiazek; P E Rollin; F Villinger; S R Zaki; C J Peters; A A Ansari
Journal:  Emerg Infect Dis       Date:  2000 Mar-Apr       Impact factor: 6.883

6.  Distribution of IgG subclasses in antimonial unresponsive Indian kala-azar patients.

Authors:  M Chatterjee; K Basu; D Basu; D Bannerjee; N Pramanik; S K Guha; R P Goswami; S K Saha; C Mandal
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

7.  IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test.

Authors:  Tapan Bhattacharyya; Armon Ayandeh; Andrew K Falconar; Shyam Sundar; Sayda El-Safi; Marissa A Gripenberg; Duncan E Bowes; Caroline Thunissen; Om Prakash Singh; Rajiv Kumar; Osman Ahmed; Osama Eisa; Alfarazdeg Saad; Sara Silva Pereira; Marleen Boelaert; Pascal Mertens; Michael A Miles
Journal:  PLoS Negl Trop Dis       Date:  2014-10-23

8.  Natural Mosquito-Pathogen Hybrid IgG4 Antibodies in Vector-Borne Diseases: A Hypothesis.

Authors:  Berlin Londono-Renteria; Jenny C Cardenas; Andrea Troupin; Tonya M Colpitts
Journal:  Front Immunol       Date:  2016-09-29       Impact factor: 7.561

9.  Host and parasite responses in human diffuse cutaneous leishmaniasis caused by L. amazonensis.

Authors:  Stephen M Christensen; Ashton T Belew; Najib M El-Sayed; Wagner L Tafuri; Fernando T Silveira; David M Mosser
Journal:  PLoS Negl Trop Dis       Date:  2019-03-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.